Szarka CE - Search Results

1

Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed.

Lewis NL, Scher R, Gallo JM, Engstrom PF, Szarka CE, Litwin S, Adams AL, Kilpatrick D, Brady D, Weiner LM, Meropol NJ. Lewis NL, et al. Among authors: szarka ce. Cancer Chemother Pharmacol. 2002 Oct;50(4):257-65. doi: 10.1007/s00280-002-0500-0. Epub 2002 Aug 21. Cancer Chemother Pharmacol. 2002. PMID: 12357298 Clinical Trial.

2

Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.

Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, Langer CJ, Litwin S, Yeslow G, Halberr T, Qian M, Gallo JM. Hudes GR, et al. Among authors: szarka ce. Clin Cancer Res. 2000 Aug;6(8):3071-80. Clin Cancer Res. 2000. PMID: 10955786 Clinical Trial.

3

Chronic dosing of oltipraz in people at increased risk for colorectal cancer.

Szarka CE, Yao KS, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg EB, Engstrom PF, Clapper ML, O'Dwyer PJ. Szarka CE, et al. Cancer Detect Prev. 2001;25(4):352-61. Cancer Detect Prev. 2001. PMID: 11531012 Clinical Trial.

4

Pharmacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose.

O'Dwyer PJ, Szarka C, Brennan JM, Laub PB, Gallo JM. O'Dwyer PJ, et al. Clin Cancer Res. 2000 Dec;6(12):4692-6. Clin Cancer Res. 2000. PMID: 11156221 Clinical Trial.

5

Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.

Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, Litwin S, Goosenberg EB, Frucht H, Engstrom PF, et al. Szarka CE, et al. Cancer Res. 1995 Jul 1;55(13):2789-93. Cancer Res. 1995. PMID: 7796404

6

Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

O'Dwyer PJ, Szarka CE, Yao KS, Halbherr TC, Pfeiffer GR, Green F, Gallo JM, Brennan J, Frucht H, Goosenberg EB, Hamilton TC, Litwin S, Balshem AM, Engstrom PF, Clapper ML. O'Dwyer PJ, et al. Among authors: szarka ce. J Clin Invest. 1996 Sep 1;98(5):1210-7. doi: 10.1172/JCI118904. J Clin Invest. 1996. PMID: 8787684 Free PMC article. Clinical Trial.

7

Chemoprevention of cancer.

Szarka CE, Grana G, Engstrom PF. Szarka CE, et al. Curr Probl Cancer. 1994 Jan-Feb;18(1):6-79. doi: 10.1016/0147-0272(94)90003-5. Curr Probl Cancer. 1994. PMID: 8005001 Review.

8

Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity.

Clapper ML, Szarka CE, Pfeiffer GR, Graham TA, Balshem AM, Litwin S, Goosenberg EB, Frucht H, Engstrom PF. Clapper ML, et al. Among authors: szarka ce. Clin Cancer Res. 1997 Jan;3(1):25-30. Clin Cancer Res. 1997. PMID: 9815533 Clinical Trial.

9

Trimodality therapy for advanced gallbladder cancer.

Sasson AR, Hoffman JP, Ross E, Meropol NJ, Szarka CE, Freedman G, Pinover W, Pingpank JF, Eisenberg BL. Sasson AR, et al. Among authors: szarka ce. Am Surg. 2001 Mar;67(3):277-83; discussion 284. Am Surg. 2001. PMID: 11270889

10

Glutathione S-transferases--biomarkers of cancer risk and chemopreventive response.

Clapper ML, Szarka CE. Clapper ML, et al. Among authors: szarka ce. Chem Biol Interact. 1998 Apr 24;111-112:377-88. doi: 10.1016/s0009-2797(97)00174-9. Chem Biol Interact. 1998. PMID: 9679568 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters